tetano
Editor, Senior Moderator
BMC Public Health
. 2026 Aug 21;26(1):3402.
doi: 10.1186/s12889-026-28818-8.
Xin Sun 1 , Zhuoran Huang 2 , Jiayu Sang 1 3 , Peipei Guo 1 , Jiani Zhang 1 , Jiaxin Li 1 , Jiahui Si 4 , Wei Ma 1 , Kaida Ning 5 , Xinxue Liu 6 , George Fu Gao 7 8 9 , Jun Liu 10
Affiliations Expand
Background: Although COVID-19 pandemic has no longer been classified as an international public health emergency of concern after May 2023, multiple variants with different characteristics keep emerging, especially considering the recently low-level circulation of BA.3.2. Given the complex spatial-temporal characteristics of epidemics, responding to potential changes in variants is a significant public health challenge. Serotypes are defined as unique variants within specific immune response characteristics, which are used in the study of various pathogens. The sero-epidemiological features of COVID-19 may offer a new perspective for variant surveillance and public health preparedness.
Methods: Based on the global SARS-CoV-2 genome deposition data in Our World in Data (OWID) based on GISAID from March 1, 2021 to May 3, 2024, we analyzed the epidemic features of different variants based on the serotype concept and combined with cross-sectional studies.
Results: In the dataset comprising variants from 58 countries or regions with complete information, we calculated the median duration times of epidemic, the median epidemic peak times for Serotypes Ⅱ-Ⅴ and the median alternation times of epidemic for Serotypes I-Ⅱ to Ⅴ-Ⅵ respectively. An increasing trend was observed during these time period between the epidemics of Serotypes Ⅱ, Ⅲ, Ⅳ and Ⅴ, except the longer duration time for Serotype I. By constructing a regression and curve regression equation, the potential emerging of a new serotype can be explored, and a possible time window for its emergence- around 2025, or even later, which may match with the emerging of BA.3.2.
Conclusion: The gradually-increased prevalence periods for SARS-CoV-2 serotypes except Serotype I may suggest a slowing down mutation rate. Understanding the epidemic time of different serotypes can provide insight into the surveillance and forecasting of COVID-19.
Keywords: Forecast; Prevalence; SARS-CoV-2; Serotypes; Slow.
. 2026 Aug 21;26(1):3402.
doi: 10.1186/s12889-026-28818-8.
Emergence of novel SARS-CoV-2 variants keeps slowing down
Xin Sun 1 , Zhuoran Huang 2 , Jiayu Sang 1 3 , Peipei Guo 1 , Jiani Zhang 1 , Jiaxin Li 1 , Jiahui Si 4 , Wei Ma 1 , Kaida Ning 5 , Xinxue Liu 6 , George Fu Gao 7 8 9 , Jun Liu 10
Affiliations Expand
- PMID: 43040267
- PMCID: PMC13776228
- DOI: 10.1186/s12889-026-28818-8
Abstract
Background: Although COVID-19 pandemic has no longer been classified as an international public health emergency of concern after May 2023, multiple variants with different characteristics keep emerging, especially considering the recently low-level circulation of BA.3.2. Given the complex spatial-temporal characteristics of epidemics, responding to potential changes in variants is a significant public health challenge. Serotypes are defined as unique variants within specific immune response characteristics, which are used in the study of various pathogens. The sero-epidemiological features of COVID-19 may offer a new perspective for variant surveillance and public health preparedness.
Methods: Based on the global SARS-CoV-2 genome deposition data in Our World in Data (OWID) based on GISAID from March 1, 2021 to May 3, 2024, we analyzed the epidemic features of different variants based on the serotype concept and combined with cross-sectional studies.
Results: In the dataset comprising variants from 58 countries or regions with complete information, we calculated the median duration times of epidemic, the median epidemic peak times for Serotypes Ⅱ-Ⅴ and the median alternation times of epidemic for Serotypes I-Ⅱ to Ⅴ-Ⅵ respectively. An increasing trend was observed during these time period between the epidemics of Serotypes Ⅱ, Ⅲ, Ⅳ and Ⅴ, except the longer duration time for Serotype I. By constructing a regression and curve regression equation, the potential emerging of a new serotype can be explored, and a possible time window for its emergence- around 2025, or even later, which may match with the emerging of BA.3.2.
Conclusion: The gradually-increased prevalence periods for SARS-CoV-2 serotypes except Serotype I may suggest a slowing down mutation rate. Understanding the epidemic time of different serotypes can provide insight into the surveillance and forecasting of COVID-19.
Keywords: Forecast; Prevalence; SARS-CoV-2; Serotypes; Slow.